FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168283959> ?p ?o ?g. }

• W2168283959 endingPage "3348" @default.
• W2168283959 startingPage "3336" @default.
• W2168283959 abstract "Biomarkers of brain Aβ amyloid deposition can be measured either by cerebrospinal fluid Aβ42 or Pittsburgh compound B positron emission tomography imaging. Our objective was to evaluate the ability of Aβ load and neurodegenerative atrophy on magnetic resonance imaging to predict shorter time-to-progression from mild cognitive impairment to Alzheimer’s dementia and to characterize the effect of these biomarkers on the risk of progression as they become increasingly abnormal. A total of 218 subjects with mild cognitive impairment were identified from the Alzheimer’s Disease Neuroimaging Initiative. The primary outcome was time-to-progression to Alzheimer’s dementia. Hippocampal volumes were measured and adjusted for intracranial volume. We used a new method of pooling cerebrospinal fluid Aβ42 and Pittsburgh compound B positron emission tomography measures to produce equivalent measures of brain Aβ load from either source and analysed the results using multiple imputation methods. We performed our analyses in two phases. First, we grouped our subjects into those who were ‘amyloid positive’ (n = 165, with the assumption that Alzheimer's pathology is dominant in this group) and those who were ‘amyloid negative’ (n = 53). In the second phase, we included all 218 subjects with mild cognitive impairment to evaluate the biomarkers in a sample that we assumed to contain a full spectrum of expected pathologies. In a Kaplan–Meier analysis, amyloid positive subjects with mild cognitive impairment were much more likely to progress to dementia within 2 years than amyloid negative subjects with mild cognitive impairment (50 versus 19%). Among amyloid positive subjects with mild cognitive impairment only, hippocampal atrophy predicted shorter time-to-progression (P < 0.001) while Aβ load did not (P = 0.44). In contrast, when all 218 subjects with mild cognitive impairment were combined (amyloid positive and negative), hippocampal atrophy and Aβ load predicted shorter time-to-progression with comparable power (hazard ratio for an inter-quartile difference of 2.6 for both); however, the risk profile was linear throughout the range of hippocampal atrophy values but reached a ceiling at higher values of brain Aβ load. Our results are consistent with a model of Alzheimer’s disease in which Aβ deposition initiates the pathological cascade but is not the direct cause of cognitive impairment as evidenced by the fact that Aβ load severity is decoupled from risk of progression at high levels. In contrast, hippocampal atrophy indicates how far along the neurodegenerative path one is, and hence how close to progressing to dementia. Possible explanations for our finding that many subjects with mild cognitive impairment have intermediate levels of Aβ load include: (i) individual subjects may reach an Aβ load plateau at varying absolute levels; (ii) some subjects may be more biologically susceptible to Aβ than others; and (iii) subjects with mild cognitive impairment with intermediate levels of Aβ may represent individuals with Alzheimer’s disease co-existent with other pathologies." @default.
• W2168283959 created "2016-06-24" @default.
• W2168283959 creator A5005099850 @default.
• W2168283959 creator A5013894575 @default.
• W2168283959 creator A5021394368 @default.
• W2168283959 creator A5022452703 @default.
• W2168283959 creator A5023136222 @default.
• W2168283959 creator A5034225628 @default.
• W2168283959 creator A5043086041 @default.
• W2168283959 creator A5043921358 @default.
• W2168283959 creator A5045246745 @default.
• W2168283959 creator A5050718938 @default.
• W2168283959 creator A5051155849 @default.
• W2168283959 creator A5059027860 @default.
• W2168283959 creator A5072237281 @default.
• W2168283959 creator A5085569895 @default.
• W2168283959 creator A5088891117 @default.
• W2168283959 date "2010-10-08" @default.
• W2168283959 modified "2023-10-15" @default.
• W2168283959 title "Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease" @default.
• W2168283959 cites W1967642097 @default.
• W2168283959 cites W1970300450 @default.
• W2168283959 cites W1971566856 @default.
• W2168283959 cites W1979121852 @default.
• W2168283959 cites W1979127061 @default.
• W2168283959 cites W1980529166 @default.
• W2168283959 cites W1984283611 @default.
• W2168283959 cites W1985262420 @default.
• W2168283959 cites W1987011701 @default.
• W2168283959 cites W1987096559 @default.
• W2168283959 cites W1988370080 @default.
• W2168283959 cites W1990502495 @default.
• W2168283959 cites W1990752558 @default.
• W2168283959 cites W1997301424 @default.
• W2168283959 cites W1997417397 @default.
• W2168283959 cites W1998088268 @default.
• W2168283959 cites W1999367055 @default.
• W2168283959 cites W2000406026 @default.
• W2168283959 cites W2001688761 @default.
• W2168283959 cites W2002776021 @default.
• W2168283959 cites W2003428745 @default.
• W2168283959 cites W2005503435 @default.
• W2168283959 cites W2006247983 @default.
• W2168283959 cites W2006858320 @default.
• W2168283959 cites W2008152557 @default.
• W2168283959 cites W2008301592 @default.
• W2168283959 cites W2013391120 @default.
• W2168283959 cites W2013435225 @default.
• W2168283959 cites W2014897304 @default.
• W2168283959 cites W2015896685 @default.
• W2168283959 cites W2020128956 @default.
• W2168283959 cites W2023484964 @default.
• W2168283959 cites W2025836081 @default.
• W2168283959 cites W2028989537 @default.
• W2168283959 cites W2030847210 @default.
• W2168283959 cites W2031489026 @default.
• W2168283959 cites W2032122310 @default.
• W2168283959 cites W2040434160 @default.
• W2168283959 cites W2050784521 @default.
• W2168283959 cites W2052132290 @default.
• W2168283959 cites W2052389355 @default.
• W2168283959 cites W2054007740 @default.
• W2168283959 cites W2054089714 @default.
• W2168283959 cites W2054093987 @default.
• W2168283959 cites W2055077265 @default.
• W2168283959 cites W2058046532 @default.
• W2168283959 cites W2063367301 @default.
• W2168283959 cites W2066462635 @default.
• W2168283959 cites W2068338689 @default.
• W2168283959 cites W2069476204 @default.
• W2168283959 cites W2070054259 @default.
• W2168283959 cites W2070267512 @default.
• W2168283959 cites W2074079071 @default.
• W2168283959 cites W2075193321 @default.
• W2168283959 cites W2075275965 @default.
• W2168283959 cites W2075348467 @default.
• W2168283959 cites W2078524519 @default.
• W2168283959 cites W2084617446 @default.
• W2168283959 cites W2086978209 @default.
• W2168283959 cites W2087924155 @default.
• W2168283959 cites W2088129757 @default.
• W2168283959 cites W2089588548 @default.
• W2168283959 cites W2093978410 @default.
• W2168283959 cites W2104954974 @default.
• W2168283959 cites W2106931873 @default.
• W2168283959 cites W2108150542 @default.
• W2168283959 cites W2111642028 @default.
• W2168283959 cites W2113169386 @default.
• W2168283959 cites W2113708991 @default.
• W2168283959 cites W2117602475 @default.
• W2168283959 cites W2118993423 @default.
• W2168283959 cites W2122328291 @default.
• W2168283959 cites W2124114508 @default.
• W2168283959 cites W2124681501 @default.
• W2168283959 cites W2126927216 @default.
• W2168283959 cites W2127360394 @default.
• W2168283959 cites W2128422359 @default.
• W2168283959 cites W2129047299 @default.

• next